TAIJI GROUP: The frozen amount in the subsidiary's bank account has decreased from 62.9212 million yuan to 20 million yuan

TAIJI GROUP announced that its holding subsidiary, Southwest Pharmaceutical, has had the amount of frozen funds in some bank accounts reduced from RMB 62.9212 million to RMB 20 million due to a dispute over a drug sales contract. The funds of RMB 42.9212 million frozen in the case of the sales contract dispute between Tibet Huiye Pharmaceutical Technology Co., Ltd. and Southwest Pharmaceutical have all been unfrozen, and the bank accounts have resumed normal use. The freezing of bank account funds during this period did not have a significant impact on the company's main operations